Characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients: A systematic review and meta-analysis

Abstract

Background We aimed to determine the characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients. Methods PubMed, Embase, Web of Science, and Scopus databases were searched to retrieve articles on readmitted COVID-19 patients, available up to September 25, 2021. All studies comparing characteristics of readmitted and non-readmitted COVID-19 patients were included. We also included articles reporting the reasons for readmission in COVID-19 patients. Data were pooled and meta-analyzed using random or fixed-effect models, as appropriate. Subgroup analyses were conducted based on the place and duration of readmission. Results Our meta-analysis included 4823 readmitted and 63,413 non-readmitted COVID-19 patients. The re-hospitalization rate was calculated at 9.3% with 95% Confidence Interval (CI) [5.5%–15.4%], mostly associated with respiratory or cardiac complications (48% and 14%, respectively). Comorbidities including cerebrovascular disease (Odds Ratio (OR) = 1.812; 95% CI [1.547–2.121]), cardiovascular (2.173 [1.545–3.057]), hypertension (1.608 [1.319–1.960]), ischemic heart disease (1.998 [1.495–2.670]), heart failure (2.556 [1.980–3.300]), diabetes (1.588 [1.443–1.747]), cancer (1.817 [1.526–2.162]), kidney disease (2.083 [1.498–2.897]), chronic pulmonary disease (1.601 [1.438–1.783]), as well as older age (1.525 [1.175–1.978]), male sex (1.155 [1.041–1.282]), and white race (1.263 [1.044–1.528]) were significantly associated with higher readmission rates ( P < 0.05 for all instances). The mortality rate was significantly lower in readmitted patients (OR = 0.530 [0.329–0.855], P = 0.009). Conclusions Male sex, white race, comorbidities, and older age were associated with a higher risk of readmission among previously admitted COVID-19 patients. These factors can help clinicians and policy-makers predict, and conceivably reduce the risk of readmission in COVID-19 patients.

Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study

“…This evidence occurred despite the increased clinical and pharmacological experience and the start of the immunization program in December 2021 in Italy. Many risk factors have been associated with acute respiratory distress syndrome development and worsened clinical outcomes from COVID-19 [ 17 , 18 , 19 ]. As shown in previous papers, some comorbidities are closely related to intensive care admission and poor prognosis (e.g., hypertension, CLD, diabetes, and CKD) [ 20 ].…”

Persistent COVID-19 symptoms at least one month after diagnosis: A national survey

“…Several factors were associated with increased risk of readmission. In a recent meta-analysis, the most important predictors of readmission were, the age, male sex and comorbidities such as cardiovascular disease, cerebrovascular disease, cancer, kidney disease, COPD, diabetes and hypertension [35] .…”

The Provision of Dental Care to COVID-19 Survivors: A Concise Review

“…They need close monitoring, even after discharge, as the ongoing systemic inflammation may lead to ventricular dysfunction and malignant arrythmia 46 . Persistent symptoms may include hypotension, tachycardia, palpitations, dyspnoea and arrhythmias 47 , 48 , 49 , 50 , with some requiring hospital readmission 51 . There are increased risks of incident cardiovascular disease, such as cerebrovascular disorders (stroke/transient ischaemic attacks), dysrhythmia (atrial fibrillation/sinus tachycardia), ischaemic heart disease (acute coronary disease/myocardial infarction/angina), thromboembolic disease (pulmonary embolism/deep vein thrombosis), heart failure, pericarditis, myocarditis, cardiac arrest and cardiogenic shock 49 , 52 , 53 , 54 , 55 , 56 .…”